U.S., Feb. 19 -- ClinicalTrials.gov registry received information related to the study (NCT06832306) titled 'STimulation to Activate RespIration' on Feb. 06.
Brief Summary: Multi-center, randomized, controlled, open-label Phase 2 feasibility trial. Subjects on mechanical ventilation (MV) for acute hypoxemic respiratory failure (AHRF) with lung injury (including subjects who meet criteria for acute respiratory distress syndrome (ARDS)) will be randomized 2:1 to diaphragm neurostimulation-assisted ventilation (DNAV) using the AeroNova System plus lung-protective ventilation (Treatment) vs. lung-protective ventilation alone (Control).
Study Start Date: Feb., 2025
Study Type: INTERVENTIONAL
Condition:
ARDS (Moderate or Severe)
AHRF
Mechani...